Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

Menopause carries increased metabolic syndrome risk

15 Jul 2020

Menopausal women, regardless of age, are at risk of developing metabolic syndrome, as suggested in a study. The perimenopausal period may thus be an important preventive care opportunity to evaluate metabolic risk factors and improve health and longevity of women.

The cross-sectional analysis included 12,611 women aged 45–85 years who participated in the Canadian Longitudinal Study on Aging. Of these, 10,035 women (79.6 percent) had undergone menopause and 2,576 (20.4 percent) were premenopausal.

Significantly more postmenopausal than premenopausal women met the criteria for metabolic syndrome (32.6 percent vs 20.5 percent; p<0.001). Using the lower waist circumference threshold, the prevalence increased slightly although still higher among postmenopausal women (38.2 percent vs 23.2 percent; p<0.001).

Multivariable modified Poisson regression analysis revealed that the risk of metabolic syndrome using the unified criteria was not significantly elevated in the presence of menopause (adjusted relative risk [aRR], 1.09, 95 percent confidence interval [CI], 0.99–1.19). However, menopause was associated with a significantly higher risk of metabolic syndrome when using the lower waist circumference criterion (aRR, 1.10, 95 percent CI, 1.01–1.19).

There was a significant risk increase observed for the following conditions: impaired glucose tolerance (aRR, 1.42, 95 percent CI, 1.26–1.59), elevated blood pressure (aRR, 1.12, 95 percent CI, 1.03–1.21), and elevated triglycerides (aRR, 1.17, 95 percent CI, 1.08–1.26).

Lifestyle interventions targeted at women with metabolic syndrome may prevent the development of type 2 diabetes mellitus and cardiovascular disease, the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.